No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- G6_AD_WIDE, F5_DEMENTIA, F5_DEMENTIA_U, F5_PSYCH, NEURODIS, MEMLOSS, TRAUMBRAIN_NONCONCUS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Alzheimer’s disease (Early onset), excluding more controls
based on the number of shared cases.
Similar with more cases:
- Alzheimer’s disease (Early onset)
- Alzheimer’s disease, wide definition, excluding more controls
- Alzheimer’s disease, wide definition
- Unspecific neurodegenerative disorder
- Any dementia, excluding more controls
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 33683 | 20929 | 12434 |
| Only index persons | 27051 | 17263 | 9788 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.50 | 0.60 | 0.35 |
| Only index persons | 0.54 | 0.63 | 0.37 |
| Median age at first event (years) | |||
| Whole population | 80.07 | 81.15 | 78.31 |
| Only index persons | 80.19 | 81.30 | 78.22 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1879 | 914 | 965 |
| Unadjusted period prevalence (%) | 0.37 | 0.31 | 0.43 |
| Median age at first event (years) | 76.41 | 74.94 | 77.80 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1565
- Matched controls
- 15165
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G30.0
ICD-10 Finland
Alzheimer disease with early onset
+∞
323.0
892
*
N06DX01
ATC
memantine; oral
855.1
323.0
885
23
N06DA03
ATC
rivastigmine; oral, transdermal
1433.6
323.0
504
5
F03
ICD-10 Finland
Unspecified dementia
109.1
323.0
370
43
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
+∞
323.0
941
*
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
2565.0
323.0
633
*
N06DA02
ATC
donepezil; oral
979.8
323.0
832
17
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
382.9
323.0
387
13
N05AX08
ATC
risperidone; systemic
98.5
323.0
496
71
G30.1
ICD-10 Finland
Alzheimer disease with late onset
359.4
323.0
722
36
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
323.0
528
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
24.3
300.2
445
244
N05AH04
ATC
quetiapine; oral
23.5
280.8
420
233
F0009, G300
ICD-10 Finland
NA
+∞
229.4
217
*
P20
ICPC
Memory disturbance
10.4
228.6
502
661
N06DA04
ATC
galantamine; oral
406.3
220.6
219
6
G30
ICD-10 Finland
Alzheimer disease
2229.6
197.9
190
*
F00.00
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
+∞
196.9
187
*
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
2059.3
186.1
179
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
202.9
178.9
185
10
P70
ICPC
Dementia
65.7
159.5
186
31
G30.8
ICD-10 Finland
Other Alzheimer disease
150.7
157.7
167
12
TAB00
NOMESCO Finland
Lumbar puncture
44.4
155.1
194
48
F0019, G301
ICD-10 Finland
NA
+∞
148.7
142
*
N03AG01
ATC
valproic acid; systemic, rectal
112.1
134.9
147
14
XA800
NOMESCO Finland
Neuropsychological investigation
242.1
133.6
137
6
F009, G309
ICD-10 Finland
NA
+∞
116.8
112
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
113.3
109.2
119
11
AA1AD
NOMESCO Finland
CT of head and brain
5.4
109.2
375
838
N05BA04
ATC
oxazepam; oral
4.4
108.2
477
1384
F06.7
ICD-10 Finland
Mild cognitive disorder
35.6
105.3
138
41
SPAT1053
SPAT
Memory test
4.7
103.8
414
1081
N06AB04
ATC
citalopram; systemic
5.0
103.4
378
900
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
102.0
98
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
102.0
98
*
S06.0
ICD-10 Finland
Concussion
29.2
100.3
138
50
N06AX11
ATC
mirtazapine; oral
3.9
98.2
489
1565
N06AB10
ATC
escitalopram; oral
6.3
96.3
283
516
R53
ICD-10 Finland
Malaise and fatigue
4.3
94.6
417
1188
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
82.1
91.1
103
13
N05AH03
ATC
olanzapine; systemic
88.0
91.0
102
12
F32.9
ICD-10 Finland
Depressive episode, unspecified
21.6
88.4
133
65
R41.3
ICD-10 Finland
Other amnesia
36.8
87.0
113
32
F00.9
ICD-10 Finland
Dementia in Alzheimer disease, unspecified
868.4
86.5
85
*
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
42.0
86.3
109
27
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
11.9
85.3
163
146
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.2
82.2
570
2308
SPAT1245
SPAT
Provision of support and information to patient’s family members
8.2
76.7
181
237
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
12.2
72.8
137
118
G40.9
ICD-10 Finland
Epilepsy, unspecified
707.5
70.8
70
*
A28
ICPC
Limited function/disability NOS
3.4
68.2
391
1345
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
66.9
357
1159
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
66.7
596
2764
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
7.0
65.2
171
261
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
623.0
62.5
62
*
G47.3
ICD-10 Finland
Sleep apnoea
14.9
60.7
104
72
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
11.0
59.4
117
110
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.6
57.6
300
944
Z2445
NOMESCO Finland
Psychologist
105.9
57.5
63
6
Z75.5
ICD-10 Finland
Holiday relief care
31.3
57.3
77
25
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
570.6
57.3
57
*
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.9
55.6
198
438
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
54.9
53
*
SPAT1216
SPAT
Assessment of functional ability
3.3
54.5
325
1130
N05BA06
ATC
lorazepam; systemic, sublingual
6.7
54.1
145
227
R56.8
ICD-10 Finland
Other and unspecified convulsions
13.9
54.0
95
70
R41.0
ICD-10 Finland
Disorientation, unspecified
13.1
53.7
97
76
SPAT1234
SPAT
Support of social functional capacity
6.2
52.7
150
254
N05AD01
ATC
haloperidol; systemic
8.5
52.1
119
146
G20
ICD-10 Finland
Parkinson disease
137.9
51.5
55
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
26.6
50.8
71
27
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
7.2
50.2
128
186
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
4.1
49.8
212
557
A06AD11
ATC
lactulose; oral
2.8
48.2
374
1537
F05.1
ICD-10 Finland
Delirium superimposed on dementia
+∞
47.6
46
*
WYA20
NOMESCO Finland
Home visit
20.8
43.9
66
32
F05.9
ICD-10 Finland
Delirium, unspecified
71.2
43.6
50
7
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.0
43.4
282
1026
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
219.0
42.6
44
*
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
+∞
42.4
41
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.0
41.9
281
1042
L28
ICPC
Limited function/disability (L)
2.8
40.7
302
1194
G56.0
ICD-10 Finland
Carpal tunnel syndrome
9.7
39.8
83
87
SPAT1254
SPAT
Administration of medicine
2.9
39.6
276
1048
F00.20
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
203.7
39.5
41
*
N05AD03
ATC
melperone; systemic
17.8
39.2
62
35
N06AB06
ATC
sertraline; oral
5.9
37.5
110
193
F00.09
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking
+∞
37.2
36
*
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
81.6
36.5
41
5
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
36.2
35
*
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
47.5
35.3
43
9
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
34.2
278
1148
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
23.9
33.6
48
20
R55
ICD-10 Finland
Syncope and collapse
3.0
33.0
209
738
F00.01
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism
+∞
32.0
31
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
+∞
32.0
31
*
N02BE01
ATC
paracetamol; systemic, rectal
2.0
31.6
1153
8884
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
19.1
31.3
48
25
F00
ICD-10 Finland
Dementia in Alzheimer disease
+∞
31.0
30
*
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
31.0
30
*
N06AX16
ATC
venlafaxine; oral
4.9
30.8
104
215
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
298.3
29.5
30
*
R42
ICD-10 Finland
Dizziness and giddiness
2.3
29.4
308
1446
G31.0
ICD-10 Finland
Circumscribed brain atrophy
+∞
28.9
28
*
N05CD07
ATC
temazepam; oral
2.4
28.6
266
1173
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
27.9
27
*
SPAT1251
SPAT
Organisation of medication
4.8
27.8
96
203
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
143.0
27.3
29
*
N07AA05
ATC
NA
+∞
26.8
26
*
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
8.6
26.7
59
69
130
Kela drug reimbursment
Malignant tumour
0.2
26.5
22
1157
Z02.4
ICD-10 Finland
Examination for driving licence
0.4
26.5
89
2227
F01.9
ICD-10 Finland
Vascular dementia, unspecified
28.8
25.9
35
12
J01CA08
ATC
pivmecillinam; oral
1.9
25.9
529
3246
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
+∞
25.8
25
*
N06AX26
ATC
vortioxetine; oral
10.4
25.3
50
48
SPAT1229
SPAT
Assessment of need for aid
3.1
24.8
142
467
F0014, G301
ICD-10 Finland
NA
+∞
24.8
24
*
F00.1
ICD-10 Finland
Dementia in Alzheimer disease with late onset
+∞
24.8
24
*
F22.0
ICD-10 Finland
Delusional disorder
127.9
24.3
26
*
F29
ICD-10 Finland
Unspecified nonorganic psychosis
127.9
24.3
26
*
W19
ICD-10 Finland
Unspecified fall
3.1
24.3
139
456
S72.0
ICD-10 Finland
Fracture of neck of femur
3.4
24.2
123
370
ACC51
NOMESCO Finland
Release of median nerve
47.6
24.0
29
6
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.6
23.9
114
326
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
23.7
23
*
F0029, G308
ICD-10 Finland
NA
+∞
23.7
23
*
N03AF01
ATC
carbamazepine; oral, rectal
5.5
23.6
71
129
N03AX14
ATC
levetiracetam; systemic
37.0
23.6
30
8
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
23.4
216
942
F001, G301
ICD-10 Finland
NA
+∞
22.7
22
*
N06AX21
ATC
duloxetine; oral
4.0
22.6
94
239
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
7.4
22.4
54
73
N03AF02
ATC
oxcarbazepine; oral
25.5
22.3
31
12
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
22.2
197
843
F0004, G300
ICD-10 Finland
NA
+∞
21.7
21
*
N05AB03
ATC
perphenazine; systemic, rectal
15.7
21.5
35
22
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
20.6
20
*
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
20.6
20
*
N05AN01
ATC
lithium; oral
75.4
20.4
23
*
F00.19
ICD-10 Finland
Dementia in Alzheimer's disease with late onset without information about additional symptoms
206.0
20.4
21
*
N06AB03
ATC
fluoxetine; oral
3.1
20.3
120
400
G72.8
ICD-10 Finland
Other specified myopathies
108.0
20.3
22
*
N05CF01
ATC
zopiclone; oral
1.8
20.1
490
3128
S70.0
ICD-10 Finland
Contusion of hip
4.4
20.0
73
165
A04
ICPC
Weakness/tiredness general
2.4
19.9
182
789
N05BA01
ATC
diazepam; systemic, rectal
2.4
19.8
183
797
N02AA05
ATC
oxycodone; systemic
2.0
19.7
269
1399
E86
ICD-10 Finland
Volume depletion
5.1
19.6
63
124
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
19.6
19
*
F00.0
ICD-10 Finland
Dementia in Alzheimer disease with early onset
+∞
19.6
19
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.0
19.5
64
129
T36
ICD-10 Finland
Poisoning by systemic antibiotics
11.5
19.4
36
31
N04AA02
ATC
biperiden; systemic
45.1
18.9
23
5
N05AA02
ATC
levomepromazine; systemic
6.0
18.8
52
86
N03AE01
ATC
clonazepam; systemic
5.1
18.6
59
115
F00.14
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type
+∞
18.6
18
*
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
3.2
18.6
100
315
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
68.5
18.5
21
*
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.0
18.3
253
1319
J01EA01
ATC
trimethoprim; systemic
1.8
18.1
388
2369
S06.3
ICD-10 Finland
Focal brain injury
+∞
17.5
17
*
N05AH02
ATC
clozapine; systemic
+∞
17.5
17
*
G31.8
ICD-10 Finland
Other specified degenerative diseases of nervous system
+∞
17.5
17
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
+∞
17.5
17
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
+∞
17.5
17
*
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
+∞
17.5
17
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
65.3
17.5
20
*
S01.0
ICD-10 Finland
Open wound of scalp
3.0
17.5
102
340
N28
ICPC
Limited function/disability (N)
17.7
17.5
27
15
I95.1
ICD-10 Finland
Orthostatic hypotension
4.0
17.2
69
171
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
3.7
17.1
77
211
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
12.9
17.1
30
23
K90
ICPC
Stroke/cerebrovascular accident
17.0
16.6
26
15
F02.39*G20
ICD-10 Finland
Dementia in Parkinson's disease without information on additional symptoms
+∞
16.5
16
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
16.5
16
*
3472A
ICD-9 Finland
Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]
+∞
16.5
16
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
+∞
16.5
16
*
F000, G300
ICD-10 Finland
NA
+∞
16.5
16
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.0
16.5
232
1217
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.1
16.4
197
966
N03AX09
ATC
lamotrigine; oral
17.5
16.2
25
14
R1250
NOMESCO Finland
Evaluation of functional capability
8.4
16.1
35
41
J01DB01
ATC
cefalexin; oral
1.6
15.9
974
7774
A10AE04
ATC
insulin glargine; parenteral
2.5
15.9
127
513
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
58.7
15.6
18
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
15.5
15
*
F00.04
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type
+∞
15.5
15
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
15.5
15
*
E000001
ATC
NA
1.9
15.3
252
1399
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
156.4
15.3
16
*
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.2
15.3
172
819
N30.0
ICD-10 Finland
Acute cystitis
2.1
15.3
185
911
SPAT1301
SPAT
No procedures
1.7
15.1
401
2588
SPAT1252
SPAT
Overall medication plan or its review
2.7
15.0
107
402
L89
ICD-10 Finland
Decubitus ulcer and pressure area
5.9
14.7
41
69
SPAT1360
SPAT
Extensive global examination
2.7
14.7
105
397
-
ICD-10 Finland
NA
4.9
14.6
48
98
Z13.3
ICD-10 Finland
Special screening examination for mental and behavioural disorders
55.4
14.6
17
*
R11
ICD-10 Finland
Nausea and vomiting
2.7
14.6
105
400
H02AB02
ATC
dexamethasone; systemic
0.3
14.6
29
938
SPAT1172
SPAT
Guidance concerning hydration
3.8
14.5
61
159
F0001, G300
ICD-10 Finland
NA
+∞
14.4
14
*
LAITO
NOMESCO Finland
NA
+∞
14.4
14
*
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
+∞
14.4
14
*
F0009, G309
ICD-10 Finland
NA
+∞
14.4
14
*
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
+∞
14.4
14
*
G31.9
ICD-10 Finland
Degenerative disease of nervous system, unspecified
+∞
14.4
14
*
N05AX12
ATC
aripiprazole; systemic
+∞
14.4
14
*
R51.80
ICD-10 Finland
Headache
2.8
14.4
93
332
N04BD01
ATC
selegiline; oral
78.3
14.4
16
*
F05.8
ICD-10 Finland
Other delirium
146.6
14.3
15
*
Z29
ICPC
Social problem NOS
7.4
14.1
33
44
N05AF03
ATC
chlorprothixene; systemic
26.6
14.1
19
7
N30.9
ICD-10 Finland
Cystitis, unspecified
2.8
13.6
87
307
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
13.4
343
2179
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
13.4
356
2287
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
13.4
13
*
35399
ICD-8 Finland
Sciatica
+∞
13.4
13
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
13.4
13
*
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
+∞
13.4
13
*
C10AA01
ATC
simvastatin; oral
1.5
13.2
659
4934
N05AC02
ATC
thioridazine; oral
17.8
13.1
20
11
B01AC07
ATC
dipyridamole; systemic
2.5
13.1
102
405
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.1
12.9
40
77
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
7.1
12.9
31
43
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
22.0
12.7
18
8
SPAT1101
SPAT
Orthostatic test
2.9
12.7
79
277
N06AG02
ATC
moclobemide; oral
4.8
12.6
41
84
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
6.8
12.5
31
45
P29
ICPC
Psychological sympt/compl other
6.8
12.5
31
45
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
68.2
12.4
14
*
G91.0
ICD-10 Finland
Communicating hydrocephalus
+∞
12.4
12
*
F00.11
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism
+∞
12.4
12
*
N05AF05
ATC
zuclopenthixol; systemic
+∞
12.4
12
*
S72.1
ICD-10 Finland
Pertrochanteric fracture
3.2
12.3
65
204
B03BA03
ATC
hydroxocobalamin; parenteral
2.2
12.1
121
548
A69
ICPC
General and Unspecified, Other reason for encounter NEC
3.7
12.0
52
140
SPAT1139
SPAT
Nutrition survey
3.9
11.9
49
126
N05BA12
ATC
alprazolam; oral
2.4
11.9
102
429
U04
ICPC
Incontinence urine
2.9
11.9
73
252
F32.1
ICD-10 Finland
Moderate depressive episode
12.1
11.9
21
17
F34.1
ICD-10 Finland
Dysthymia
20.8
11.8
17
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
11.8
468
3308
H04AA01
ATC
glucagon; nasal, parenteral
8.0
11.8
26
32
N03AB02
ATC
phenytoin; systemic
13.1
11.7
20
15
SPAT1304
SPAT
Counselling and guidance related to ageing
2.1
11.6
129
609
P72
ICPC
Schizophrenia
63.4
11.4
13
*
30041
ICD-8 Finland
Neuroses, Depressiva
+∞
11.3
11
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
+∞
11.3
11
*
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
+∞
11.3
11
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
11.3
11
*
G25.8
ICD-10 Finland
Other specified extrapyramidal and movement disorders
+∞
11.3
11
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
+∞
11.3
11
*
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
117.0
11.3
12
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.1
11.2
124
589
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
11.5
11.1
20
17
G56.2
ICD-10 Finland
Lesion of ulnar nerve
11.5
11.1
20
17
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
34.2
11.1
14
*
N87
ICPC
Parkinsonism
34.2
11.1
14
*
C04AE01
ATC
ergoloid mesylates; systemic
6.2
11.1
29
46
N06AA09
ATC
amitriptyline; systemic
2.4
11.0
95
398
Z02.7
ICD-10 Finland
Issue of medical certificate
2.7
11.0
74
273
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
5.0
10.9
34
67
P01
ICPC
Feeling anxious/nervous/tense
4.3
10.9
39
89
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.1
10.8
121
574
N29
ICPC
Neurological sympt/complt other
7.8
10.8
24
30
G44.2
ICD-10 Finland
Tension-type headache
2.9
10.8
67
234
A10AE05
ATC
insulin detemir; parenteral
2.8
10.8
69
247
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
10.6
98
426
G45.3
ICD-10 Finland
Amaurosis fugax
27.3
10.6
14
5
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
58.5
10.5
12
*
G04CA02
ATC
tamsulosin; oral
1.5
10.3
382
2645
2900A
ICD-9 Finland
Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated
+∞
10.3
10
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
+∞
10.3
10
*
F00.02
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions
+∞
10.3
10
*
N07AA06
ATC
NA
+∞
10.3
10
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
10.3
10
*
N04BA03
ATC
levodopa, decarboxylase inhibitor and COMT inhibitor; oral
+∞
10.3
10
*
AAF00
NOMESCO Finland
Ventriculostomy
+∞
10.3
10
*
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
+∞
10.3
10
*
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
2.2
10.3
104
474
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
107.2
10.3
11
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
10.2
79
315
NFJ54
NOMESCO Finland
Internal fixation of fracture of upper femur with intramedullary nail
3.6
10.2
45
124
N06AA12
ATC
doxepin; systemic
2.8
10.2
63
220
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.2
10.2
101
458
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
10.1
206
1217
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.7
10.1
67
244
N06AB05
ATC
paroxetine; oral
3.8
10.0
41
106
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.3
10.0
36
83
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
4.0
10.0
39
97
G04BD07
ATC
tolterodine; oral
2.3
10.0
87
371
S18
ICPC
Laceration/cut
0.6
9.9
248
3443
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
39.0
9.8
12
*
R41
ICD-10 Finland
Other symptoms and signs involving cognitive functions and awareness
9.8
9.8
19
19
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
16.3
9.7
15
9
K91
ICPC
Cerebrovascular disease
25.4
9.7
13
5
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
25.4
9.7
13
5
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
3.4
9.6
45
131
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
53.6
9.5
11
*
F99
ICD-10 Finland
Mental disorder, not otherwise specified
53.6
9.5
11
*
N06AX03
ATC
mianserin; oral
3.5
9.4
43
123
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.3
516
3869
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
9.3
172
985
G31.1
ICD-10 Finland
Senile degeneration of brain, not elsewhere classified
97.4
9.3
10
*
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
97.4
9.3
10
*
F02.09*G31.0
ICD-10 Finland
Dementia in Pick's disease without information on additional symptoms
+∞
9.3
9
*
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
+∞
9.3
9
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
+∞
9.3
9
*
F009, F03
ICD-10 Finland
NA
+∞
9.3
9
*
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
+∞
9.3
9
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
9.3
9
*
F0011, G301
ICD-10 Finland
NA
+∞
9.3
9
*
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
9.3
9
*
G40.10
ICD-10 Finland
Simple partial seizures
+∞
9.3
9
*
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
+∞
9.3
9
*
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
+∞
9.3
9
*
SPAT1240
SPAT
Therapeutic discussion
3.1
9.3
49
156
SPAT1167
SPAT
Insertion of urinary catheter
2.8
9.2
58
205
ZXD05
NOMESCO Finland
Urgent procedure
1.5
9.2
372
2614
N19
ICPC
Speech disorder
21.1
9.2
13
6
N99
ICPC
Neurological disease other
21.1
9.2
13
6
SPAT1307
SPAT
Psychosocial counselling and guidance
4.9
9.0
28
56
SPAT1153
SPAT
Removal of sutures
0.6
9.0
170
2512
A29
ICPC
General symptom/complaint other
1.9
8.9
134
718
EBA15
NOMESCO Finland
Extraction of large number of teeth
3.1
8.9
47
150
N06AX12
ATC
bupropion; oral
8.1
8.9
19
23
N18
ICPC
Paralysis/weakness
8.8
8.8
18
20
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.7
8.8
208
1281
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
5.4
8.8
25
45
SPAT1246
SPAT
Screening of depression or other psychiatric problem
5.3
8.6
25
46
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
8.4
8.6
18
21
D07AA02
ATC
hydrocortisone; topical
1.8
8.5
145
812
SPAT1262
SPAT
Handing over of treatment supplies
1.6
8.5
205
1273
E0000UV
ATC
NA
1.4
8.4
413
3015
SPAT1276
SPAT
Outlining of treatment with patient or their family members
3.6
8.4
36
98
P99
ICPC
Psychological disorders other
15.9
8.4
13
8
Z28
ICPC
Limited function/disability (Z)
11.3
8.4
15
13
F10.20
ICD-10 Finland
Alcohol dependence currently independent
87.7
8.3
9
*
N04BC04
ATC
ropinirole; oral
87.7
8.3
9
*
F10.09
ICD-10 Finland
Alcohol intoxication UNS
87.7
8.3
9
*
N05BE01
ATC
buspirone; oral
6.2
8.3
21
33
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
+∞
8.2
8
*
ACC53
NOMESCO Finland
Release of ulnar nerve
+∞
8.2
8
*
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
+∞
8.2
8
*
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
+∞
8.2
8
*
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
8.2
8
*
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
8.2
8
*
3310A
ICD-9 Finland
Other cerebral degenerations, Alzheimer's disease
+∞
8.2
8
*
F01.0
ICD-10 Finland
Vascular dementia of acute onset
+∞
8.2
8
*
R33
ICD-10 Finland
Retention of urine
1.8
8.2
135
747
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
0.1
8.1
*
256
R32
ICD-10 Finland
Unspecified urinary incontinence
3.2
8.1
40
122
A10BB12
ATC
glimepiride; oral
1.8
8.1
134
741
SPAT1263
SPAT
Sampling
1.4
8.1
444
3308
A03FA01
ATC
metoclopramide; systemic, rectal
0.6
8.1
127
1961
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
14.1
8.0
13
9
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
6.9
8.0
19
27
L82
ICD-10 Finland
Seborrhoeic keratosis
0.5
8.0
64
1187
A04AA01
ATC
ondansetron; systemic, rectal
0.3
8.0
14
482
K92.0
ICD-10 Finland
Haematemesis
2.9
8.0
47
162
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.8
7.8
48
170
P28
ICPC
Limited function/disability (P)
12.7
7.7
13
10
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.5
7.7
60
1122
SPAT1050
SPAT
Extensive neurological examination
4.6
7.7
25
53
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.7
198
1247
SPAT1243
SPAT
Psychiatric/psychological examination
10.5
7.6
14
13
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.9
7.6
104
538
N05AL01
ATC
sulpiride; systemic
8.2
7.6
16
19
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.9
7.6
104
539
M03BX01
ATC
baclofen; systemic
9.2
7.6
15
16
IGY02
NOMESCO Finland
Psychiatric monitoring contact
43.8
7.6
9
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.2
7.6
71
315
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
3.8
7.6
30
77
A02BC03
ATC
lansoprazole; oral
1.4
7.6
357
2577
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
7.6
334
2382
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.5
338
2421
P76
ICPC
Depressive disorder
5.1
7.5
22
42
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
24.3
7.5
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
7.4
429
3216
P03
ICPC
Feeling depressed
3.4
7.4
34
99
I63.8
ICD-10 Finland
Other cerebral infarction
77.9
7.3
8
*
Z60.8
ICD-10 Finland
Other problems related to social environment
77.9
7.3
8
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
77.9
7.3
8
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
77.9
7.3
8
*
R40.0
ICD-10 Finland
Somnolence
77.9
7.3
8
*
R40.2
ICD-10 Finland
Coma, unspecified
6.9
7.3
17
24
G51.0
ICD-10 Finland
Bell palsy
13.0
7.2
12
9
H02AA02
ATC
fludrocortisone; oral
7.4
7.2
16
21
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
+∞
7.2
7
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
7.2
7
*
G21.9
ICD-10 Finland
Secondary parkinsonism, unspecified
+∞
7.2
7
*
29599
ICD-8 Finland
Schizophrenia, Unspecified type
+∞
7.2
7
*
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
+∞
7.2
7
*
30320
ICD-8 Finland
Alcoholism, Alcoholic addiction
+∞
7.2
7
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
+∞
7.2
7
*
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
+∞
7.2
7
*
F00, F03
ICD-10 Finland
NA
+∞
7.2
7
*
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
+∞
7.2
7
*
F0002, G300
ICD-10 Finland
NA
+∞
7.2
7
*
KMAK
NOMESCO Finland
NA
1.4
7.2
422
3168
WX402
NOMESCO Finland
General anaesthesia
0.4
7.2
40
836
SPAT1279
SPAT
Preparation of immediate hospitalisation
4.0
7.1
27
67
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
15.3
7.1
11
7
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
7.1
64
279
Z75.0
ICD-10 Finland
Medical services not available in home
29.2
7.0
9
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
29.2
7.0
9
*
I95.9
ICD-10 Finland
Hypotension, unspecified
4.4
7.0
24
54
Z60.9
ICD-10 Finland
Problem related to social environment, unspecified
19.5
7.0
10
5
N05AC01
ATC
periciazine; systemic
19.5
7.0
10
5
SPAT1104
SPAT
Monitoring of emergency patient
2.1
7.0
78
372
S22.3
ICD-10 Finland
Fracture of rib
2.2
7.0
71
325
N03AX16
ATC
pregabalin; oral
1.6
6.9
189
1212
N06AX05
ATC
trazodone; oral
5.9
6.9
18
30
T89
ICPC
Diabetes insulin dependent
3.7
6.8
28
75
JN4AD
NOMESCO Finland
Body CT examination
0.4
6.8
20
538
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.8
6.8
21
43
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.0
6.8
25
61
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.6
6.7
163
1012
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.6
6.7
197
1281
G04BD08
ATC
solifenacin; oral
2.0
6.7
87
444
F10.24
ICD-10 Finland
Alcohol depence active use
38.9
6.7
8
*
K86
ICPC
Hypertension uncomplicated
0.5
6.6
52
971
XF606
NOMESCO Finland
Ortostatic test
9.1
6.6
13
14
F41.1
ICD-10 Finland
Generalized anxiety disorder
9.1
6.6
13
14
N06AX18
ATC
reboxetine; oral
16.2
6.6
10
6
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
6.6
283
2003
ZXD35
NOMESCO Finland
Usual procedure
2.6
6.5
43
161
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
4.8
6.5
20
41
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
6.5
55
234
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
6.5
149
911
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
11.9
6.5
11
9
L57.0
ICD-10 Finland
Actinic keratosis
0.5
6.4
61
1075
PA7BD
NOMESCO Finland
CT angiography of neck and brain
9.7
6.4
12
12
SPAT1138
SPAT
Guidance concerning bowel function
3.9
6.4
24
60
S00.0
ICD-10 Finland
Superficial injury of scalp
3.8
6.3
25
65
P04
ICPC
Feeling/behaving irritable/angry
67.9
6.3
7
*
Z10.1
ICD-10 Finland
Routine general health check-up of inhabitants of institutions
67.9
6.3
7
*
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.8
6.3
37
128
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.6
6.3
109
1650
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
6.3
282
2010
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.8
6.3
99
540
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
6.0
6.3
16
26
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
6.3
88
463
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
6.3
152
941
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
6.3
351
2608
-2
ICPC
NA
5.2
6.3
18
34
N02AJ06
ATC
codeine and paracetamol; systemic
0.7
6.2
155
2175
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.1
6.2
*
230
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.0
6.2
32
103
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
0.2
6.2
7
307
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
7.9
6.2
13
16
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
+∞
6.2
6
*
F00.03
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression
+∞
6.2
6
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
+∞
6.2
6
*
S06.9
ICD-10 Finland
Intracranial injury, unspecified
+∞
6.2
6
*
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
+∞
6.2
6
*
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
+∞
6.2
6
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
6.2
6
*
4359X
ICD-9 Finland
Transient cerebral ischaemia, Unspecified transient cerebral ischaemia
+∞
6.2
6
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
+∞
6.2
6
*
G40
ICD-10 Finland
Epilepsy
+∞
6.2
6
*
F00.21
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism
+∞
6.2
6
*
F0009, G301
ICD-10 Finland
NA
+∞
6.2
6
*
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
+∞
6.2
6
*
G44.0
ICD-10 Finland
Cluster headache syndrome
+∞
6.2
6
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
+∞
6.2
6
*
F31.8
ICD-10 Finland
Other bipolar affective disorders
+∞
6.2
6
*
3074A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]
+∞
6.2
6
*
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
+∞
6.2
6
*
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
+∞
6.2
6
*
WX780
NOMESCO Finland
Remote monitoring CPAP
+∞
6.2
6
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
+∞
6.2
6
*
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
+∞
6.2
6
*
F06.0
ICD-10 Finland
Organic hallucinosis
+∞
6.2
6
*
F0001, G301
ICD-10 Finland
NA
+∞
6.2
6
*
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
+∞
6.2
6
*
F0003, G300
ICD-10 Finland
NA
+∞
6.2
6
*
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
+∞
6.2
6
*
N03AX18
ATC
lacosamide; systemic
+∞
6.2
6
*
F00.13
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression
+∞
6.2
6
*
F0023, G308
ICD-10 Finland
NA
+∞
6.2
6
*
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
10.7
6.2
11
10
A10BA02
ATC
metformin; oral
1.4
6.2
348
2587
XA400
NOMESCO Finland
EEG
17.5
6.2
9
5
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.8
6.1
105
591
L01BC06
ATC
capecitabine; oral
0.2
6.1
6
287
C03CA01
ATC
furosemide; systemic
1.3
6.1
554
4442
M01AB55
ATC
diclofenac, combinations; oral
1.8
6.1
92
497
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
6.1
115
667
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.2
6.1
*
244
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.8
6.1
108
615
N05AF01
ATC
flupentixol; systemic
6.8
6.1
14
20
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.0
462
3612
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
195
52
39.41
301.54
1.1
1.1
mg/l
415.3
562.5
0.97
184
46
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
184
40
48.06
298.80
1.1
1.1
e6/l
2.2
16.7
0.50
146
28
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
184
40
48.06
298.80
1.2
1.2
e6/l
120.7
25.8
1.77
150
28
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
183
47
40.64
285.53
1.1
1.1
mmol/l
3.7
3.7
0.25
172
41
(3044290) Cell count panel - Cerebral spinal fluid
149
43
35.45
224.71
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
87
18
47.79
141.70
1.2
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
61
20
29.72
87.80
1.1
1.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
493
2136
2.60
65.13
1.8
1.7
nmol/l
1216.3
1143.5
0.95
348
1533
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
48
22
21.10
61.10
1.0
1.0
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
38
15
24.38
51.11
1.0
1.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
718
9844
0.49
46.25
3.8
4.2
mmol/l
1.5
1.5
0.04
617
8691
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
771
10310
0.50
45.81
4.1
4.8
mmol/l
2.6
2.7
0.64
661
9110
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
733
9966
0.49
45.80
3.8
4.3
mmol/l
4.5
4.6
0.69
638
8880
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
693
9490
0.50
42.60
3.4
3.8
mmol/l
1.2
1.2
0.14
587
8294
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
834
10211
0.58
27.62
4.1
4.6
mmol/l
6.2
6.0
1.93
701
8925
(40768804) Tissue Pathology biopsy report
244
4289
0.47
27.17
1.9
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
802
9885
0.59
26.84
15.5
14.6
ml/min/173m2
72.3
69.7
2.59
589
8032
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
25
21
11.37
23.15
1.3
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
798
9625
0.62
21.99
5.8
5.9
mmol/mol
42.8
40.5
4.77
667
8559
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
26
7
35.53
20.21
1.2
1.0
%
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
170
3051
0.48
18.88
3.1
3.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
220
3555
0.53
17.50
3.5
3.7
mg/mmol
5.3
7.9
0.88
134
2184
(3012516) Albumin [Mass/volume] in Urine
201
3301
0.52
16.75
2.7
3.0
mg/l
33.6
225.6
2.87
124
2027
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
138
2567
0.47
16.73
1.5
1.6
mmol/l
1.3
1.3
0.28
115
2097
(3021589) Normoblasts [#/volume] in Blood
317
4563
0.58
16.51
8.1
9.1
e9/l
0.0
0.0
0.31
240
3624
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
374
2293
1.67
16.17
1.7
1.7
pmol/l
457.3
18233089.3
1.25
304
1788
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
12
12.68
15.74
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
350
4861
0.60
15.61
3.8
4.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
209
3322
0.54
15.44
2.6
2.9
mmol/l
7.3
6.8
0.94
152
2664
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
998
11096
0.67
15.22
7.6
9.6
u/l
23.1
23.8
0.35
899
10479
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
15
10.78
15.17
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
624
7596
0.66
15.13
3.8
3.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
16
13
11.70
15.01
1.1
1.2
nmol/l
125.3
135.8
0.21
16
13
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
391
2481
1.62
14.61
2.5
1.7
u/l
264.8
193.6
1.06
354
2242
(4035726)
38
1105
0.31
12.73
1.2
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
724
8397
0.69
12.59
19.8
18.4
%
13.9
14.0
0.46
679
8125
(3019150) Specific gravity of Urine by Refractometry
337
2143
1.59
12.28
5.4
3.8
kg/l
1.0
1.0
0.61
49
340
(3003694) ABO and Rh group [Type] in Blood
159
2571
0.54
12.11
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
40
108
3.55
11.89
1.8
2.4
umol/l
34.1
34.2
0.00
33
81
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
16
8.91
11.72
1.1
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
233
1368
1.69
11.61
8.9
7.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
26
52
4.77
11.43
1.0
1.7
—
—
—
0
0
(40761535) Cells panel - Urine sediment
161
855
1.85
11.32
3.7
3.1
—
—
—
0
0
(3002256) Pathology report gross observation
76
1532
0.45
11.18
1.4
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
355
4626
0.66
11.00
5.1
5.2
%
60.2
58.9
1.10
311
4225
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
104
482
2.10
10.82
1.5
1.4
%
1.6
1.5
0.22
87
409
(3019198) Lymphocytes [#/volume] in Blood
393
4968
0.68
10.28
5.2
5.1
e9/l
1.7
1.8
1.39
319
4189
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
0
+∞
10.19
14.6
0.0
nmol/l
685.7
—
—
10
0
(3001604) Monocytes [#/volume] in Blood
382
4839
0.68
10.05
5.3
5.0
e9/l
0.6
0.6
1.28
310
3984
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
6
22.16
9.93
1.2
1.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
372
4724
0.68
9.88
5.0
5.5
%
25.2
25.8
0.35
321
4295
(3022096) Basophils/100 leukocytes in Blood
351
4501
0.67
9.79
4.5
5.3
%
0.6
0.6
0.39
304
4103
(3006315) Basophils [#/volume] in Blood
388
4871
0.69
9.64
5.2
5.0
e9/l
0.0
0.0
1.87
312
4006
(3006504) Eosinophils/100 leukocytes in Blood
363
4613
0.68
9.62
4.9
5.3
%
2.8
2.8
0.10
316
4197
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
1213
0.43
9.62
1.2
1.2
u/ml
7.1
19.6
1.68
19
425
(3013650) Neutrophils [#/volume] in Blood by Automated count
480
5798
0.70
9.58
7.1
8.2
e9/l
4.6
4.3
1.57
394
4900
(4027681)
15
9
15.84
9.55
1.2
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
403
5017
0.69
9.54
5.2
5.1
e9/l
0.2
0.2
0.86
323
4209
(3019069) Monocytes/100 leukocytes in Blood
365
4626
0.68
9.52
5.4
5.5
%
8.6
9.0
1.12
320
4224
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
558
4108
1.40
9.51
4.1
3.6
ng/l
65.9
73.9
0.19
399
3101
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
315
2095
1.50
9.18
2.6
3.2
mmol/l
2.4
2.5
5.41
242
1775
(3015377) Calcium [Moles/volume] in Serum or Plasma
497
3608
1.41
9.12
2.1
3.5
mmol/l
2.3
2.4
0.65
398
3018
(3026493) Urate [Moles/volume] in Serum or Plasma
195
2777
0.62
8.84
2.3
2.7
umol/l
3442.2
8695.1
1.45
156
2319
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
78
1406
0.50
8.30
2.1
4.2
ug/l
7.4
24.0
1.46
62
1179
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
81
1439
0.51
8.24
2.1
3.8
u/l
250.8
254.2
0.09
65
1340
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
70
1301
0.49
8.17
1.2
1.2
iu/ml
22.2
45.8
1.96
21
401
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
159
2321
0.61
7.95
2.7
3.3
ug/l
1.0
0.9
0.17
109
1663
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
184
2580
0.64
7.70
2.1
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
261
3397
0.68
7.56
2.1
2.5
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
11
8.62
7.55
1.1
1.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
259
3358
0.68
7.32
3.8
5.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
12
7.90
7.07
1.1
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
12
7.90
7.07
1.1
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
12
7.90
7.07
1.1
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
66
305
2.08
7.01
1.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
111
612
1.76
6.95
1.6
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
45
4.01
6.84
2.7
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
128
738
1.68
6.83
1.5
1.5
—
—
—
0
0
(3000492) Spirometry study
31
730
0.39
6.71
1.3
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
49
959
0.47
6.65
1.2
1.3
titre
388.6
606.1
—
7
216
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
54
1017
0.49
6.57
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
366
2651
1.38
6.56
5.1
3.8
estimate
0.0
0.0
0.50
61
858
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
588
4603
1.30
6.15
2.0
2.0
pmol/l
95.3
91.2
1.09
276
2231
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
1609
0.60
6.00
2.2
2.4
%
20.7
21.1
0.11
75
1360
(3019832) Treponema pallidum Ab [Presence] in Serum
40
162
2.36
5.88
1.1
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
428
3234
1.32
5.73
3.9
4.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
855
7061
1.26
5.70
5.8
4.4
e6/l
2240.6
2343.1
0.02
36
113
(3014271) Vancomycin [Susceptibility]
20
57
3.34
5.59
3.6
2.9
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
130
1837
0.64
5.56
3.1
2.9
e6/l
3.3
2.7
0.26
72
1026
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
329
3930
0.74
5.45
3.9
5.4
ug/l
3.9
6.0
1.15
276
3449
(3026008) Bacteria identified in Urine by Culture
474
3655
1.30
5.45
3.7
3.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
139
1922
0.66
5.36
2.7
2.8
e6/l
1.8
1.3
0.67
80
1103
(3028707) Methadone [Presence] in Urine by Screen method
8
5
15.15
5.24
1.3
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
683
7392
0.80
5.12
3.2
3.7
mm/h
14.1
15.9
2.13
591
6619
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
0
+∞
5.09
1.6
0.0
nmol/l
148.6
—
—
5
0
(3013512) EKG study
283
3424
0.74
5.07
3.9
4.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
121
1700
0.65
5.04
1.9
2.3
g/l
2.2
2.2
0.49
98
1546
(3022145) Colonoscopy Study observation
62
1024
0.56
4.99
1.2
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
10
18
5.26
4.92
1.3
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
255
3120
0.73
4.91
3.3
3.1
e6/l
0.6
0.6
0.05
204
2331
(3006270) Folate [Moles/volume] in Blood
25
89
2.67
4.83
1.1
1.2
nmol/l
346.0
344.3
0.01
20
65
(40761511) CBC panel - Blood by Automated count
1032
10636
0.81
4.72
16.6
13.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1123
11453
0.81
4.54
22.9
21.4
e9/l
242.4
242.0
0.08
1025
10971
(3018677) aPTT in Platelet poor plasma by Coagulation assay
188
1294
1.41
4.52
1.6
1.9
s
29.2
30.6
3.76
180
1253
(3000963) Hemoglobin [Mass/volume] in Blood
1124
11460
0.81
4.52
22.9
21.5
g/l
129.3
131.5
4.98
1039
11167
(3026361) Erythrocytes [#/volume] in Blood
1124
11456
0.81
4.48
22.8
21.4
e12/l
4.3
4.4
4.41
1016
10926
(3024731) MCV [Entitic volume]
1124
11455
0.81
4.47
22.7
21.3
fl
91.5
91.7
1.27
1043
11156
(3035941) MCH [Entitic mass]
1124
11454
0.81
4.46
22.7
21.3
pg
30.3
30.4
1.07
1042
11155
(3024561) Albumin [Mass/volume] in Serum or Plasma
578
4663
1.25
4.44
3.4
4.3
g/l
34.7
34.1
1.40
490
4222
(3010813) Leukocytes [#/volume] in Blood
1125
11459
0.81
4.42
22.8
21.4
e9/l
7.1
6.9
2.31
1018
10926
(3009445) Proteinase 3 Ab [Units/volume] in Serum
15
398
0.35
4.33
1.1
1.6
—
21.8
—
0
15
(3009542) Hematocrit [Volume Fraction] of Blood
872
9097
0.82
4.29
17.7
16.7
%
36.6
37.9
1.68
447
5829
(40760892) CBC W Ordered Manual Differential panel - Blood
148
1934
0.70
4.24
4.3
4.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
63
989
0.59
4.23
4.6
5.4
mmol/l
13.3
12.6
0.22
55
914
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
150
1005
1.44
4.20
2.6
2.3
ug/l
6.6
6.5
0.02
99
835
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
12
7.10
4.17
1.1
1.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
401
0.37
4.10
1.2
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
138
1815
0.69
4.10
1.9
2.4
umol/l
11.5
11.8
0.18
109
1653
(3002179) Metamyelocytes/100 leukocytes in Blood
45
767
0.54
4.08
2.4
3.8
%
1.0
0.6
—
9
196
(3017181) Myelocytes/100 leukocytes in Blood
52
849
0.57
4.06
2.8
3.8
%
2.4
0.8
0.43
15
260
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
54
285
1.81
4.04
1.9
2.2
ug/l
1591.3
329.9
1.20
47
273
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
325
0.32
3.96
1.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
227
0.29
3.89
1.7
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
50
815
0.57
3.89
2.8
3.7
%
0.1
0.1
0.14
15
249
(3025159) Blasts/100 leukocytes in Blood
44
742
0.55
3.86
2.8
3.9
%
0.1
0.1
0.20
12
204
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
882
9137
0.83
3.83
4.2
4.2
mu/l
1.9
2.3
1.19
743
7950
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
27
530
0.47
3.81
1.7
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
65
979
0.61
3.73
1.3
2.4
g/l
65.5
65.5
0.01
54
869
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
32
3.55
3.72
1.0
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
346
3930
0.79
3.71
2.9
3.0
ng/l
2391.4
2282.8
0.12
270
3397
(3001122) Ferritin [Mass/volume] in Serum or Plasma
351
3975
0.79
3.66
2.4
2.6
ug/l
136.9
160.9
1.25
292
3542
(3003458) Phosphate [Moles/volume] in Serum or Plasma
100
1362
0.68
3.60
4.2
4.6
mmol/l
1.0
1.1
0.36
86
1226
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
37
640
0.54
3.56
1.3
1.6
g/l
1.7
1.6
0.18
22
542
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
791
8243
0.84
3.56
4.7
6.8
u/l
81.2
84.4
0.81
693
7583
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
11
303
0.34
3.49
1.4
1.6
—
117.9
—
0
19
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
63
934
0.62
3.40
1.8
2.0
g/l
0.2
0.2
0.60
53
860
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
273
3156
0.78
3.37
3.9
4.6
%
20.3
22.4
1.71
131
1745
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
6
6
9.46
3.37
1.2
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
33
580
0.53
3.37
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
257
2989
0.78
3.34
3.2
3.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
17
5.01
3.34
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
81
0.00
3.33
0.0
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
27
120
2.14
3.32
30.2
6.1
mmol/l
7.9
7.2
0.44
19
98
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
54
823
0.61
3.28
3.2
2.7
ml/min/173m2
64.4
54.6
1.26
22
357
(3011397) Hemoglobin [Presence] in Urine by Test strip
306
2374
1.26
3.23
5.1
3.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
461
0.48
3.23
1.0
2.1
g/l
4.2
3.8
0.92
18
323
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
50
278
1.72
3.20
1.5
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
50
278
1.72
3.20
1.5
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
14
5.41
3.18
1.3
1.0
miu/ml
2065.1
1860.8
—
8
14
(4094501)
9
232
0.36
3.06
1.2
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
282
0.36
3.04
1.3
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
463
0.50
3.03
1.0
2.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
25
463
0.50
3.03
1.0
2.1
g/l
7.7
7.6
0.08
19
337
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
760
0.61
3.03
1.3
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
243
1850
1.28
3.01
1.8
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
219
2565
0.78
3.00
3.2
3.6
%
84.3
83.1
0.24
208
2501
(3007164) IgA [Mass/volume] in Serum or Plasma
105
1367
0.71
2.98
1.3
1.5
g/l
2.6
2.7
0.37
53
763
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
74
0.00
2.96
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
74
0.00
2.96
0.0
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
517
5525
0.84
2.93
3.8
5.8
umol/l
12.7
12.9
0.12
455
5199
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
101
1318
0.71
2.91
3.9
4.2
%
33.6
33.6
0.00
61
765
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
10
28
3.38
2.91
1.4
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
5
9.45
2.87
1.2
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
165
1993
0.76
2.87
1.5
1.5
mg/l
2.0
1.7
0.20
111
1535
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
470
3858
1.20
2.87
5.1
3.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
849
0.64
2.83
1.4
1.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
223
2587
0.79
2.82
5.2
6.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
10
258
0.36
2.82
1.2
1.5
—
13.1
—
0
6
(3028026) IgM [Mass/volume] in Serum or Plasma
27
475
0.53
2.81
2.0
1.8
g/l
2.1
1.4
0.48
21
413
(40768441) Liver Pathology biopsy report
0
68
0.00
2.79
0.0
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
577
0.58
2.72
9.3
8.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
203
0.37
2.68
1.4
2.2
%
183.6
204.3
—
8
189
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
413
0.52
2.58
4.3
2.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
1556
0.75
2.58
2.2
2.8
mmol/l
0.8
0.8
0.87
112
1401
(3023520) Reticulocytes [#/volume] in Blood
82
1084
0.70
2.57
1.8
2.5
e9/l
62.8
65.9
0.38
65
805
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
40
613
0.61
2.55
3.4
6.6
mmol/l
24.6
24.8
0.11
40
607
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
19
3.98
2.53
1.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
42
240
1.67
2.50
1.2
1.1
—
—
—
0
0
(3015736) pH of Urine
466
3874
1.18
2.43
4.5
3.3
—
5.8
—
0
6
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
11
5.16
2.43
2.7
2.2
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
11
5.16
2.43
1.8
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
11
5.16
2.43
2.7
2.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
87
1126
0.72
2.42
2.1
2.5
umol/l
11.7
9.9
0.23
67
970
(3004588) Protein electrophoresis panel - Serum or Plasma
55
774
0.66
2.41
1.4
2.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
174
1312
1.28
2.36
1.6
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
172
1296
1.28
2.35
1.7
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
221
1716
1.24
2.34
22.5
31.8
inr
1.4
1.6
0.92
21
209
(40760888) Immunoglobulin light chains.free panel - Serum
17
325
0.49
2.33
2.1
3.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
48
688
0.65
2.31
3.6
3.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
33
2.87
2.28
1.3
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
27
3.15
2.24
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
451
0.58
2.21
1.1
1.1
iu/ml
57.9
175.9
1.43
14
143
(3023103) Potassium [Moles/volume] in Serum or Plasma
1116
11095
0.87
2.19
19.1
17.6
mmol/l
4.0
4.0
0.24
1022
10703
(3027008) Opiates [Presence] in Urine
10
34
2.78
2.17
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
34
2.78
2.17
1.3
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
141
0.33
2.16
1.0
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
12
46
2.47
2.10
1.2
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
16
298
0.50
2.07
1.6
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
48
666
0.67
2.01
2.1
2.5
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1116
11064
0.88
1.99
19.2
17.4
mmol/l
140.1
139.5
6.70
1027
10688
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
20
340
0.55
1.94
1.5
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
8
179
0.42
1.93
1.0
1.3
—
440.0
—
0
8
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
10
214
0.44
1.91
1.6
1.5
pmol/l
122.3
345.9
—
10
208
(3048879) Bone marrow aspiration report
0
49
0.00
1.89
0.0
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
11
223
0.46
1.83
1.4
1.5
mg/l
3.9
3.0
—
6
172
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
48
308
1.48
1.82
2.5
3.9
mmol/l
24.4
24.5
0.15
42
265
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
172
0.44
1.82
1.3
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
222
0.46
1.82
1.0
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
33
2.58
1.79
1.3
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
17
294
0.54
1.77
1.2
1.1
—
—
—
0
0
(4281824)
5
130
0.36
1.75
2.0
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
64
819
0.73
1.73
3.1
3.4
ng/l
86.3
97.7
0.36
47
671
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
14
255
0.51
1.73
1.1
3.0
u/ml
19.1
1039.0
—
9
236
(3032057) Clostridioides difficile [Presence] in Stool
5
12
3.94
1.73
1.6
1.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
262
2845
0.85
1.72
2.5
2.8
u/l
37.4
35.1
0.23
238
2643
(40768793) Breast Pathology biopsy report
13
241
0.51
1.70
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
313
2595
1.17
1.68
1.4
1.6
nmol/l
20.8
19.9
0.47
264
2122
(3009343) pH of Capillary blood
75
532
1.34
1.65
2.4
3.7
ph
7.4
7.4
—
6
67
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
43
583
0.69
1.64
5.8
8.2
mmol/l
24.4
24.3
0.10
34
536
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
141
0.40
1.64
1.2
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
437
0.64
1.63
2.6
2.4
u/ml
0.4
0.3
0.45
17
246
(40768797) Stomach Pathology biopsy report
104
1230
0.79
1.61
1.3
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
59
2.09
1.61
1.5
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
199
2196
0.84
1.59
3.4
3.7
ng/l
326.0
578.5
0.76
158
1919
(3017732) Neutrophils [#/volume] in Blood
46
610
0.70
1.57
2.2
2.8
e9/l
5.0
4.3
0.51
29
416
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
196
0.48
1.56
1.1
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
7
147
0.45
1.56
1.7
2.0
ug/l
11.5
22.6
—
7
140
(3005570) Glucose [Moles/volume] in Urine
20
108
1.76
1.53
1.8
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
40
0.00
1.53
0.0
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
128
1466
0.81
1.51
1.9
2.4
%
1.7
1.7
0.07
97
1285
(3045142) Bone marrow Pathology biopsy report
5
120
0.39
1.50
1.6
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
191
0.49
1.46
1.7
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
36
2.36
1.45
2.0
1.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
36
2.36
1.45
2.0
1.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
189
0.50
1.42
1.7
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
71
513
1.32
1.42
2.4
3.7
mmol/l
1.2
1.8
0.81
53
357
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
16
261
0.57
1.41
1.1
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
38
2.24
1.39
5.9
43.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
54
376
1.37
1.38
2.3
3.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
44
296
1.41
1.37
3.1
3.2
mg/l
38.2
30.3
0.46
34
205
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
20
305
0.61
1.37
1.7
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
326
3421
0.88
1.36
3.3
3.2
e6/l
88.3
164.8
0.92
256
2604
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
76
911
0.78
1.35
2.4
3.5
mmol/l
1.2
1.2
0.12
61
771
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
427
4405
0.89
1.35
2.5
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
37
0.00
1.34
0.0
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
37
0.00
1.34
0.0
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
37
0.00
1.34
0.0
1.9
—
—
—
0
0
(4010399)
47
602
0.73
1.34
1.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
30
416
0.68
1.33
2.3
2.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
38
0.00
1.33
0.0
1.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
74
544
1.30
1.32
2.5
3.7
kpa
5.1
5.1
0.35
62
489
(3045424) Erythrocytes [Presence] in Urine
7
141
0.47
1.32
1.6
1.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
728
7288
0.91
1.31
3.4
3.6
pmol/l
15.1
15.2
0.20
612
6361
(3045788) Cell count panel - Pleural fluid
9
166
0.51
1.29
2.0
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
615
5413
1.11
1.28
4.8
5.9
mmol/l
1.2
1.2
3.70
494
4504
(40768443) Skin Pathology biopsy report
33
445
0.69
1.28
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
18
273
0.62
1.23
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
226
0.58
1.22
1.2
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
516
0.73
1.21
2.6
3.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
19
283
0.63
1.20
1.1
1.0
—
1.2
—
0
5
(3041096) Erythrocytes [Presence] in Urine by Automated
257
2712
0.88
1.18
3.9
3.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
56
404
1.32
1.17
1.9
1.8
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
31
0.00
1.16
0.0
1.5
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
32
0.00
1.16
0.0
3.0
—
4118.5
—
0
6
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
32
0.00
1.16
0.0
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
46
576
0.75
1.16
2.0
2.9
g/l
10.3
10.9
0.52
38
518
(3042936) Bacteria identified in Isolate by Culture
131
1452
0.84
1.14
1.9
1.8
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
8
37
2.04
1.14
1.8
6.9
mmol/l
24.7
25.4
—
8
37
(3024980) IgG subclass 4 [Mass/volume] in Serum
5
108
0.44
1.12
1.2
1.5
g/l
0.4
0.9
—
5
75
(3016502) Oxygen saturation in Arterial blood
97
1101
0.82
1.10
6.5
6.2
%
94.5
95.3
0.46
91
1054
(36660697) Celiac disease serology panel - Serum
40
506
0.74
1.09
1.2
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
42
295
1.35
1.07
6.4
2.9
mmol/l
4.1
3.9
0.32
32
272
(46235355) HIV 1 and 2 tests - Meaningful Use set
90
700
1.22
1.05
1.5
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
35
448
0.73
1.04
3.2
3.2
pmol/l
4.5
4.4
0.08
28
391
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
143
1163
1.17
1.04
3.9
3.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
168
0.56
1.03
1.8
2.7
—
—
—
0
0
(3020891) Body temperature
53
388
1.30
1.03
6.0
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
627
0.78
1.02
1.7
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
21
2.25
1.01
1.4
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
224
0.63
0.99
1.5
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
81
628
1.23
0.99
1.7
2.2
nmol/l
420.2
402.4
0.30
62
573
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
540
5420
0.92
0.98
2.9
2.6
u/l
44.6
54.2
2.31
467
4796
(3014051) Protein [Presence] in Urine by Test strip
17
245
0.65
0.97
2.9
2.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
30
0.00
0.96
0.0
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
232
0.65
0.94
1.4
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
83
933
0.83
0.89
1.9
2.2
u/l
26.6
42.7
2.32
67
791
(3014576) Chloride [Moles/volume] in Serum or Plasma
128
1386
0.86
0.88
5.4
6.0
mmol/l
105.1
104.3
0.78
118
1353
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
194
0.63
0.88
1.5
1.6
iu/l
2.0
4.5
—
5
68
(3032080) INR in Blood by Coagulation assay
454
4569
0.92
0.87
10.0
10.2
inr
1.3
1.4
0.86
115
1204
(3007566) Smooth muscle Ab [Titer] in Serum
12
182
0.62
0.87
1.1
1.2
—
97.1
—
0
7
(40761536) Microorganisms panel - Urine sediment
79
889
0.83
0.86
4.4
3.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
257
1.33
0.86
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
59
450
1.24
0.86
2.0
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
82
917
0.84
0.84
4.2
7.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
129
1.47
0.84
2.0
2.1
u/field
2.2
1.1
—
5
39
(3026782) Osmolality of Urine
219
2280
0.89
0.84
3.0
2.8
mosm/kgh2o
583.4
546.3
1.84
177
1890
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
6
105
0.54
0.83
1.2
1.5
u/l
12.5
15.3
—
6
100
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
18
247
0.68
0.83
1.4
1.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
548
4887
1.08
0.83
4.6
5.3
mmol/l
1.2
1.2
1.42
459
4337
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
259
1.32
0.82
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
105
1147
0.86
0.82
2.6
2.8
ng/l
250.0
325.4
1.00
87
1031
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
156
0.60
0.82
1.5
1.4
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
23
0.00
0.79
0.0
1.2
—
17.1
—
0
14
(3000285) Sodium [Moles/volume] in Blood
0
23
0.00
0.79
0.0
1.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
139
0.61
0.79
1.3
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
261
1.31
0.79
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
25
0.00
0.78
0.0
2.4
—
29.7
—
0
9
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
117
0.56
0.78
1.3
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
117
0.56
0.78
1.1
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
165
0.63
0.78
1.3
2.9
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
13
187
0.65
0.77
1.1
1.1
—
1468.3
—
0
6
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
32
1.77
0.76
2.3
3.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
35
422
0.78
0.74
3.8
4.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
557
4995
1.07
0.73
4.7
3.6
estimate
0.0
0.0
0.00
74
904
(3018095) Leukocytes [#/volume] in Urine
387
3886
0.92
0.71
3.9
3.6
e6/l
340.6
182.3
0.47
274
2781
(3024928) Oxygen saturation in Venous blood
18
238
0.71
0.71
1.4
2.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
95
1.49
0.70
1.2
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
666
0.83
0.70
1.7
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
171
0.66
0.69
1.8
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
116
1236
0.88
0.68
6.1
5.9
mmol/l
1.1
0.9
0.17
86
936
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
7
114
0.58
0.67
1.3
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
86
0.55
0.67
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
435
0.80
0.66
1.4
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
116
1232
0.88
0.65
6.0
6.0
kpa
11.8
11.9
0.07
103
1156
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
116
1232
0.88
0.65
6.0
6.0
kpa
4.9
5.1
0.56
103
1157
(3044941) Cell count panel - Synovial fluid
10
146
0.64
0.65
1.6
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
516
0.82
0.64
2.4
2.0
nmol/l
10.7
11.2
0.14
39
441
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
123
0.61
0.64
1.1
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
15
200
0.71
0.63
2.5
4.1
%
0.9
1.5
—
10
142
(3051651) Icteric interference index of Serum or Plasma
10
59
1.60
0.63
4.6
3.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
10
59
1.60
0.63
1.9
1.7
u/field
0.2
1.8
—
5
39
(3008898) HLA-B27 [Presence]
9
132
0.64
0.60
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
19
0.00
0.60
0.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
19
0.00
0.60
0.0
1.6
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.60
0.0
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
239
1.27
0.60
1.2
1.4
ug/g
297.2
275.0
0.28
20
140
(3024932) HLA-DR beta [Type]
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
165
0.68
0.60
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
107
1.41
0.59
4.6
2.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
8
49
1.54
0.59
1.1
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
8
49
1.54
0.59
1.1
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
21
0.00
0.59
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
21
0.00
0.59
0.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
21
0.00
0.59
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
21
0.00
0.59
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
21
0.00
0.59
0.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
346
3074
1.08
0.59
2.2
2.2
u/l
59.1
61.5
0.21
306
2787
(3004616) Nuclear Ab [Presence] in Serum
7
106
0.62
0.58
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
34
1.67
0.56
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
403
0.82
0.54
3.2
3.1
nmol/l
0.8
0.8
0.09
22
301
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
172
0.71
0.54
1.4
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
47
525
0.84
0.54
2.5
3.6
mmol/l
24.0
24.0
0.03
38
476
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
149
0.69
0.52
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
93
0.61
0.52
1.0
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
6
95
0.59
0.51
1.0
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
136
0.69
0.49
1.2
1.2
—
26.5
—
0
11
(4024509)
7
103
0.64
0.48
1.7
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
135
0.70
0.47
1.3
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
78
0.60
0.46
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
114
0.66
0.45
1.6
1.4
—
—
—
0
0
(4146454)
8
114
0.66
0.45
3.1
2.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
41
329
1.18
0.43
4.4
3.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
185
0.76
0.43
3.5
3.5
%
59.6
58.9
0.10
15
185
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
31
1.52
0.41
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
31
1.52
0.41
1.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
14
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.41
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
14
0.00
0.41
0.0
1.2
—
100.7
—
0
14
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
15
0.00
0.41
0.0
4.9
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
16
0.00
0.41
0.0
5.4
—
5.7
—
0
16
(3000494) Fungus identified in Specimen by Culture
95
985
0.91
0.40
1.2
1.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
1.1
—
0.8
—
0
5
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
33
1.43
0.39
2.2
2.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
18
0.00
0.39
0.0
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
213
0.80
0.38
2.3
2.6
%
16.0
15.0
—
7
99
(3021601) Nitrite [Presence] in Urine by Test strip
550
5027
1.05
0.38
6.1
5.1
estimate
0.0
0.0
0.00
69
900
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
152
1.24
0.36
1.4
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
74
0.64
0.35
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
74
0.64
0.35
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
200
0.80
0.35
1.2
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
78
808
0.91
0.34
2.0
2.0
ug/g
107.1
160.2
1.17
54
628
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
152
1528
0.93
0.34
1.2
1.2
u/ml
2.5
1.6
0.22
44
376
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1075
10301
0.96
0.33
17.1
14.4
mg/l
32.4
29.1
1.56
844
8139
(3009261) Glucose [Presence] in Urine by Test strip
555
5092
1.04
0.32
4.8
3.6
estimate
0.0
0.0
0.50
68
907
(3000850) Epithelial cells [#/volume] in Urine
257
2317
1.05
0.32
2.8
2.6
e6/l
6.0
5.8
0.08
220
1985
(4034850)
26
288
0.85
0.31
6.0
10.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
26
288
0.85
0.31
2.6
3.2
mmol/l
9.1
8.0
0.63
26
281
(3004119) Hemoglobin [Mass/volume] in Venous blood
64
665
0.90
0.31
2.4
2.8
g/l
126.7
123.7
0.68
64
646
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
7
95
0.69
0.30
1.3
1.1
—
0.2
—
0
6
(1616796) Gas panel - Central venous blood
27
218
1.17
0.29
2.1
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
366
0.87
0.29
1.9
3.1
g/l
0.2
0.3
—
6
149
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
31
335
0.87
0.28
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
8
59
1.28
0.28
1.1
1.2
u/l
10.4
21.8
—
8
47
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
9
113
0.75
0.27
1.1
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
114
0.74
0.27
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
72
1.31
0.27
1.1
1.1
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
8
61
1.24
0.27
1.1
1.2
u/l
58.8
94.0
—
8
51
(3026470) Cobalt [Mass/volume] in Blood
5
67
0.70
0.26
1.4
1.9
ug/l
0.9
4.3
—
5
61
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
5
69
0.68
0.26
1.2
1.0
%
123.4
115.2
—
5
59
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
5
71
0.66
0.26
1.0
1.1
—
30.2
—
0
5
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
73
744
0.92
0.25
1.5
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
97
857
1.07
0.25
2.4
2.7
kpa
4.3
4.2
0.02
87
823
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
72
1.18
0.24
1.1
1.3
—
—
—
0
0
(4306422)
9
73
1.16
0.24
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
73
1.16
0.24
1.1
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
120
1070
1.06
0.24
1.6
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
54
466
1.10
0.24
2.2
1.8
ug/l
1.3
2.9
0.86
41
398
(3003338) MCHC [Mass/volume]
871
8338
0.97
0.23
20.8
19.7
g/l
330.3
330.5
0.25
813
8218
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
437
4021
1.03
0.23
1.9
2.0
nmol/l
79.2
80.8
0.46
343
3431
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
87
0.76
0.22
1.3
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
7
88
0.75
0.22
1.3
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
13
148
0.83
0.22
1.2
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
10
0.00
0.21
0.0
9.8
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
10
0.00
0.21
0.0
2.5
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
780
7247
1.03
0.21
4.8
4.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.1
—
22.7
—
0
11
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.1
—
9.0
—
0
11
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.1
—
36.9
—
0
11
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.0
—
78.6
—
0
11
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
40
1.18
0.21
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
11
127
0.82
0.21
1.9
1.3
—
—
—
0
0
(44790048)
8
98
0.77
0.21
1.6
1.5
—
—
—
0
0
(44806118)
8
98
0.77
0.21
1.6
1.5
—
—
—
0
0
(44790049)
8
98
0.77
0.21
1.6
1.5
—
—
—
0
0
(44790047)
8
98
0.77
0.21
1.6
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
16
177
0.85
0.21
1.4
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
13
0.00
0.20
0.0
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
13
0.00
0.20
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.20
0.0
1.1
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
13
0.00
0.20
0.0
1.2
—
201.8
—
0
8
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
13
0.00
0.20
0.0
1.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.20
0.0
1.1
—
0.2
—
0
5
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
24
256
0.88
0.20
2.1
2.3
ug/min
16.9
98.2
—
10
136
(3019060) Gas panel - Arterial blood
68
686
0.93
0.20
6.3
3.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
20
216
0.87
0.20
1.3
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
50
1.13
0.18
3.0
3.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
29
303
0.90
0.18
2.1
1.6
—
—
—
0
0
(1002224) Polysomnography panel
14
112
1.18
0.18
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
120
1083
1.05
0.17
4.3
4.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
51
448
1.08
0.17
1.2
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
65
1.16
0.16
1.4
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
307
2962
0.97
0.15
2.1
2.2
mg/l
3.3
3.1
0.41
234
2448
(3021901) Oxygen saturation in Capillary blood
22
186
1.12
0.15
2.1
3.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
122
0.85
0.15
1.6
2.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
83
0.79
0.14
1.0
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
131
0.86
0.14
1.9
5.0
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
17
180
0.89
0.13
2.0
2.4
mmol/l
107.9
104.9
1.56
17
175
(3041354) Potassium [Moles/volume] in Venous blood
17
180
0.89
0.13
2.0
2.4
mmol/l
4.3
4.1
0.61
17
175
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
104
0.82
0.13
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
39
344
1.07
0.12
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
16
169
0.89
0.12
1.7
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
197
0.91
0.11
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
17
177
0.91
0.10
2.0
2.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
650
6081
1.01
0.09
4.5
3.9
mmol/l
7.3
6.8
3.18
582
5676
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
119
1.11
0.08
1.0
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
64
1.03
0.08
1.1
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
71
0.80
0.07
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
164
0.92
0.07
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
77
0.86
0.07
1.1
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
78
0.85
0.07
1.1
1.8
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
72
659
1.03
0.07
9.7
5.2
mmol/l
24.7
24.2
0.56
67
610
(3035320) C reactive protein [Mass/volume] in Body fluid
8
85
0.89
0.06
3.1
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
144
0.92
0.06
1.1
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
26
232
1.06
0.06
2.8
4.4
mmol/l
2.9
2.9
0.01
20
156
(3013290) Carbon dioxide [Partial pressure] in Blood
26
233
1.05
0.05
2.8
4.5
kpa
5.2
5.0
0.45
26
227
(3018418) pH of Serum or Plasma
341
3245
0.99
0.05
2.6
3.9
ph
7.4
7.4
0.97
50
581
(3014111) Lactate [Moles/volume] in Serum or Plasma
101
938
1.02
0.04
3.7
6.0
mmol/l
1.7
1.4
1.96
93
892
(3025468) Yersinia sp identified in Specimen by Organism specific culture
13
115
1.07
0.02
1.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
13
115
1.07
0.02
1.0
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
13
115
1.07
0.02
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
13
115
1.07
0.02
1.0
1.3
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
111
1035
1.01
0.02
2.4
3.3
kpa
5.8
5.8
0.04
102
995
(3002032) Base excess in Venous blood by calculation
111
1038
1.01
0.01
2.4
3.3
mmol/l
1.7
1.9
0.20
83
795
(3024522) Salmonella sp identified in Specimen by Organism specific culture
13
117
1.05
0.00
1.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
187
1.01
0.00
1.8
1.6
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
13
123
1.00
0.00
4.5
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
80
757
1.00
0.00
4.3
3.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
54
510
1.00
0.00
1.9
2.3
%
1.2
1.2
0.09
54
505
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
157
1.02
0.00
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
48
0.98
0.00
1.6
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
58
0.98
0.00
3.3
7.7
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
102.4
—
0
7
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.7
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
19.8
—
0
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
53
0.89
0.00
1.4
1.7
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
389.8
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
75
0.88
0.00
1.3
1.1
nmol/l
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
74
0.89
0.00
1.1
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
88
0.96
0.00
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
10.3
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
2.0
—
27.0
—
0
9
(3049242) von Willebrand panel - Platelet poor plasma
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AD_EO_EXMORE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AD_EO_EXMORE | 2.808 [2.51, 3.15] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 13192 out of 17872 females with AD_EO_EXMORE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AD_EO_EXMORE | 3.402 [2.88, 4.02] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 7808 out of 10340 males with AD_EO_EXMORE died.
Mortality risk
Mortality risk for people of age
years, who have AD_EO_EXMORE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.233% | 0.648% |
| 5 | 1.348% | 3.521% |
| 10 | 3.498% | 8.812% |
| 15 | 6.322% | 15.839% |
| 20 | 10.973% | 25.691% |
Relationships between endpoints
↥Index endpoint: AD_EO_EXMORE – Alzheimer’s disease (Early onset), excluding more controls
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data